### Comment:
What strike price do you like for the LXRX put?

### REPLY:
I'm looking into this now.  I just re-read the FDA briefing docs.  The FDA is fairly corrupt, but now I'm even more convinced sotagliflozin (the drug) gets rejected.  Page 11 of the briefing docs, ''While all patients with type 1 diabetes may to some degree be at risk for DKA, sotagliflozin therapy clearly increases that risk, and the risk may be unpredictable,'

### END.